140 related articles for article (PubMed ID: 33091481)
1. The effect of ageing and cerebral serotonin deficit on the activity of cytochrome P450 2D (CYP2D) in the brain and liver of male rats.
Haduch A; Pukło R; Alenina N; Nikiforuk A; Popik P; Bader M; Daniel WA
Neurochem Int; 2020 Dec; 141():104884. PubMed ID: 33091481
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450 2D (CYP2D) enzyme dysfunction associated with aging and serotonin deficiency in the brain and liver of female Dark Agouti rats.
Haduch A; Danek PJ; Kuban W; Pukło R; Alenina N; Gołębiowska J; Popik P; Bader M; Daniel WA
Neurochem Int; 2022 Jan; 152():105223. PubMed ID: 34780807
[TBL] [Abstract][Full Text] [Related]
3. The effect of brain serotonin deficit (TPH2-KO) on the expression and activity of liver cytochrome P450 enzymes in aging male Dark Agouti rats.
Haduch A; Bromek E; Kuban W; Basińska-Ziobroń A; Danek PJ; Alenina N; Bader M; Daniel WA
Pharmacol Rep; 2023 Dec; 75(6):1522-1532. PubMed ID: 37848703
[TBL] [Abstract][Full Text] [Related]
4. Chronic treatment with asenapine affects cytochrome P450 2D (CYP2D) in rat brain and liver. Pharmacological aspects.
Danek PJ; Bromek E; Haduch A; Daniel WA
Neurochem Int; 2021 Dec; 151():105209. PubMed ID: 34666077
[TBL] [Abstract][Full Text] [Related]
5. The activity of brain and liver cytochrome P450 2D (CYP2D) is differently affected by antidepressants in the chronic mild stress (CMS) model of depression in the rat.
Haduch A; Rysz M; Papp M; Daniel WA
Biochem Pharmacol; 2018 Oct; 156():398-405. PubMed ID: 30195732
[TBL] [Abstract][Full Text] [Related]
6. The cytochrome P450 2D-mediated formation of serotonin from 5-methoxytryptamine in the brain in vivo: a microdialysis study.
Haduch A; Bromek E; Kot M; Kamińska K; Gołembiowska K; Daniel WA
J Neurochem; 2015 Apr; 133(1):83-92. PubMed ID: 25581337
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of dextromethorphan-O-demethylase activity and distribution of CYP2D in four commonly-used subcellular fractions of rat brain.
DuBois BN; Amirrad F; Mehvar R
Xenobiotica; 2019 Oct; 49(10):1133-1142. PubMed ID: 30392427
[TBL] [Abstract][Full Text] [Related]
8. The catalytic competence of cytochrome P450 in the synthesis of serotonin from 5-methoxytryptamine in the brain: an in vitro study.
Haduch A; Bromek E; Sadakierska-Chudy A; Wójcikowski J; Daniel WA
Pharmacol Res; 2013 Jan; 67(1):53-9. PubMed ID: 23098818
[TBL] [Abstract][Full Text] [Related]
9. Selective deficiency of debrisoquine 4-hydroxylase activity in mouse liver microsomes.
Masubuchi Y; Iwasa T; Hosokawa S; Suzuki T; Horie T; Imaoka S; Funae Y; Narimatsu S
J Pharmacol Exp Ther; 1997 Sep; 282(3):1435-41. PubMed ID: 9316857
[TBL] [Abstract][Full Text] [Related]
10. The Atypical Antipsychotic Lurasidone Affects Brain but Not Liver Cytochrome P450 2D (CYP2D) Activity. A Comparison with Other Novel Neuroleptics and Significance for Drug Treatment of Schizophrenia.
Danek PJ; Daniel WA
Cells; 2022 Nov; 11(21):. PubMed ID: 36359909
[TBL] [Abstract][Full Text] [Related]
11. The effect of psychotropic drugs on cytochrome P450 2D (CYP2D) in rat brain.
Haduch A; Bromek E; Daniel WA
Eur J Pharmacol; 2011 Jan; 651(1-3):51-8. PubMed ID: 21115002
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Treatment with Atypical Antipsychotic Iloperidone Modulates Cytochrome P450 2D (CYP2D) Expression and Activity in the Liver and Brain via Different Mechanisms.
Danek PJ; Daniel WA
Cells; 2021 Dec; 10(12):. PubMed ID: 34943983
[No Abstract] [Full Text] [Related]
13. Role of brain cytochrome P450 (CYP2D) in the metabolism of monoaminergic neurotransmitters.
Anna Haduch A; Bromek E; Daniel WA
Pharmacol Rep; 2013; 65(6):1519-28. PubMed ID: 24553000
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous alterations of brain and plasma serotonin concentrations and liver cytochrome P450 in rats fed on a tryptophan-free diet.
Kot M; Pilc A; Daniel WA
Pharmacol Res; 2012 Oct; 66(4):292-9. PubMed ID: 22749902
[TBL] [Abstract][Full Text] [Related]
15. The Effect of the Selective N-methyl-D-aspartate (NMDA) Receptor GluN2B Subunit Antagonist CP-101,606 on Cytochrome P450 2D (CYP2D) Expression and Activity in the Rat Liver and Brain.
Haduch A; Bromek E; Pukło R; Jastrzębska J; Danek PJ; Daniel WA
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430225
[TBL] [Abstract][Full Text] [Related]
16. Regioselectivity and substrate concentration-dependency of involvement of the CYP2D subfamily in oxidative metabolism of amitriptyline and nortriptyline in rat liver microsomes.
Masubuchi Y; Iwasa T; Fujita S; Suzuki T; Horie T; Narimatsu S
J Pharm Pharmacol; 1996 Sep; 48(9):925-9. PubMed ID: 9036183
[TBL] [Abstract][Full Text] [Related]
17. Imipramine-induced inactivation of a cytochrome P450 2D enzyme in rat liver microsomes: in relation to covalent binding of its reactive intermediate.
Masubuchi Y; Igarashi S; Suzuki T; Horie T; Narimatsu S
J Pharmacol Exp Ther; 1996 Nov; 279(2):724-31. PubMed ID: 8930177
[TBL] [Abstract][Full Text] [Related]
18. Melatonin Supports CYP2D-Mediated Serotonin Synthesis in the Brain.
Haduch A; Bromek E; Wójcikowski J; Gołembiowska K; Daniel WA
Drug Metab Dispos; 2016 Mar; 44(3):445-52. PubMed ID: 26884482
[TBL] [Abstract][Full Text] [Related]
19. Consequences of daily corticosteroid dosing with or without pre-treatment with quinidine on the in vivo cytochrome P450 2D (CYP2D) enzyme in rats: effect on O-demethylation activity of dextromethorphan and expression levels of CYP2D1 mRNA.
Giri P; Delvadia P; Gupta L; Patel N; Trivedi P; Lad K; Patel HM; Srinivas NR
Xenobiotica; 2018 Jan; 48(1):1-10. PubMed ID: 28010169
[TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of a dog cytochrome P450 isozyme belonging to the CYP2D subfamily and development of its antipeptide antibody.
Nakamura A; Yamamoto Y; Tasaki T; Sugimoto C; Masuda M; Kazusaka A; Fujita S
Drug Metab Dispos; 1995 Nov; 23(11):1268-73. PubMed ID: 8591729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
